Importance of Combination Therapy in Type 2 Diabetes Mellitus Symposium
On January 7th, 2024, the Inya Ballroom at Novotel, Yangon, became the epicenter of a groundbreaking symposium focused on the “Importance of Combination Therapy in Type 2 Diabetes Mellitus.” Sponsored by Octelle Co., Ltd, the event saw a diverse gathering of over 150 doctors attending physically and an additional 500 doctors participating online via Zoom, reflecting the global reach and significance of the topic.
The symposium commenced with a seamless registration process and signature collection, creating an atmosphere of anticipation for the wealth of knowledge to be shared. CEO Rajesh Kumar set the stage with an inspiring opening speech, emphasizing the pivotal role of combination therapy in transforming the landscape of Type 2 Diabetes Mellitus treatment.
A key highlight of the event was the company presentation and product introduction of ‘Empaglo M,’ a moment that showcased the latest advancements in diabetes pharmaceuticals. The dynamic presentation captured the attention of both physical and virtual attendees, highlighting the symbiotic relationship between technology and medical innovation.
Under the able guidance of Chairperson Prof. Zaw Lynn Aung, the symposium delved into critical subtopics. Prof. Aung Kyaw Thu tackled the nuances of drug adherence and compliance, shedding light on practical strategies for ensuring patient commitment to treatment plans. Following this, Prof. Hein Yarzar Aung explored the intricacies of combination therapy in Type 2 Diabetes Mellitus, offering a comprehensive understanding of its applications and benefits.
The symposium’s interactive element shone during the Question & Answer session, providing a platform for attendees to directly engage with the distinguished speakers. Adding an element of excitement, a unique lucky draw incorporated balloons, where attendees eagerly popped them to reveal hidden tickets, transforming the event into a memorable experience.
As the symposium drew to a close, CEO Mr. Rajesh Kumar expressed his gratitude in the Vote of Thanks, acknowledging the active participation of both physical and virtual attendees. This symposium not only deepened our understanding of combination therapy but also fostered a sense of collaboration and shared commitment among healthcare professionals.
In conclusion, the symposium on the “Importance of Combination Therapy in Type 2 Diabetes Mellitus” transcended geographical boundaries, bringing together a diverse community of medical experts to collectively explore innovative approaches and pave the way for a more effective future in diabetes care.